These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32778310)

  • 21. Selected Pharmaceuticals in Different Aquatic Compartments: Part I-Source, Fate and Occurrence.
    Pereira A; Silva L; Laranjeiro C; Lino C; Pena A
    Molecules; 2020 Feb; 25(5):. PubMed ID: 32106570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occurrence of selected pharmaceuticals in wastewater treatment plants of Tuscany: An effect-based approach to evaluate the potential environmental impact.
    Palli L; Spina F; Varese GC; Vincenzi M; Aragno M; Arcangeli G; Mucci N; Santianni D; Caffaz S; Gori R
    Int J Hyg Environ Health; 2019 May; 222(4):717-725. PubMed ID: 31101503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Typical pharmaceuticals in major WWTPs in Beijing, China: Occurrence, load pattern and calculation reliability.
    Zhang Y; Wang B; Cagnetta G; Duan L; Yang J; Deng S; Huang J; Wang Y; Yu G
    Water Res; 2018 Sep; 140():291-300. PubMed ID: 29730561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmaceutical compound removal efficiency by a small constructed wetland located in south Brazil.
    De Vargas JPR; Bastos MC; Al Badany M; Gonzalez R; Wolff D; Santos DRD; Labanowski J
    Environ Sci Pollut Res Int; 2021 Jun; 28(24):30955-30974. PubMed ID: 33594565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic screening of common wastewater-marking pharmaceuticals in urban aquatic environments: implications for environmental risk control.
    Zhou H; Zhang Q; Wang X; Zhang Q; Ma L; Zhan Y
    Environ Sci Pollut Res Int; 2014; 21(11):7113-29. PubMed ID: 24557805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmaceuticals and personal care products (PPCPs) in Arctic environments: indicator contaminants for assessing local and remote anthropogenic sources in a pristine ecosystem in change.
    Kallenborn R; Brorström-Lundén E; Reiersen LO; Wilson S
    Environ Sci Pollut Res Int; 2018 Nov; 25(33):33001-33013. PubMed ID: 28762048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multi-phase partitioning, ecological risk and fate of acidic pharmaceuticals in a wastewater receiving river: the role of colloids.
    Duan YP; Meng XZ; Wen ZH; Ke RH; Chen L
    Sci Total Environ; 2013 Mar; 447():267-73. PubMed ID: 23391893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occurrence of Pharmaceuticals in Calgary's Wastewater and Related Surface Water.
    Chen M; Cooper VI; Deng J; Amatya PL; Ambrus D; Dong S; Stalker N; Nadeau-Bonilla C; Patel J
    Water Environ Res; 2015 May; 87(5):414-24. PubMed ID: 26460461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of pharmaceuticals in surface and wastewater from Cuernavaca, Morelos, Mexico: Occurrence and environmental risk assessment.
    Rivera-Jaimes JA; Postigo C; Melgoza-Alemán RM; Aceña J; Barceló D; López de Alda M
    Sci Total Environ; 2018 Feb; 613-614():1263-1274. PubMed ID: 28962074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A review on emerging contaminants in wastewaters and the environment: current knowledge, understudied areas and recommendations for future monitoring.
    Petrie B; Barden R; Kasprzyk-Hordern B
    Water Res; 2015 Apr; 72():3-27. PubMed ID: 25267363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmaceuticals in the Aquatic Environment: A Review on Eco-Toxicology and the Remediation Potential of Algae.
    Hejna M; Kapuścińska D; Aksmann A
    Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abundance, fate, and effects of pharmaceuticals and personal care products in aquatic environments.
    Adeleye AS; Xue J; Zhao Y; Taylor AA; Zenobio JE; Sun Y; Han Z; Salawu OA; Zhu Y
    J Hazard Mater; 2022 Feb; 424(Pt B):127284. PubMed ID: 34655870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fate of selected pharmaceuticals in hospital and municipal wastewater effluent: occurrence, removal, and environmental risk assessment.
    Ulvi A; Aydın S; Aydın ME
    Environ Sci Pollut Res Int; 2022 Oct; 29(50):75609-75625. PubMed ID: 35655023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioaccumulation and biomagnification potential of pharmaceuticals with a focus to the aquatic environment.
    Zenker A; Cicero MR; Prestinaci F; Bottoni P; Carere M
    J Environ Manage; 2014 Jan; 133():378-87. PubMed ID: 24419205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmaceuticals and personal care products in water streams: Occurrence, detection, and removal by electrochemical advanced oxidation processes.
    Lozano I; Pérez-Guzmán CJ; Mora A; Mahlknecht J; Aguilar CL; Cervantes-Avilés P
    Sci Total Environ; 2022 Jun; 827():154348. PubMed ID: 35257780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occurrence patterns of pharmaceuticals in water and wastewater environments.
    Nikolaou A; Meric S; Fatta D
    Anal Bioanal Chem; 2007 Feb; 387(4):1225-34. PubMed ID: 17205270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden.
    Bendz D; Paxéus NA; Ginn TR; Loge FJ
    J Hazard Mater; 2005 Jul; 122(3):195-204. PubMed ID: 15967274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmaceutical residues in environmental waters and wastewater: current state of knowledge and future research.
    Fatta-Kassinos D; Meric S; Nikolaou A
    Anal Bioanal Chem; 2011 Jan; 399(1):251-75. PubMed ID: 21063687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmaceuticals and iodinated contrast media in a hospital wastewater: A case study to analyse their presence and characterise their environmental risk and hazard.
    Mendoza A; Aceña J; Pérez S; López de Alda M; Barceló D; Gil A; Valcárcel Y
    Environ Res; 2015 Jul; 140():225-41. PubMed ID: 25880605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmaceuticals and environmental risk assessment in municipal wastewater treatment plants and rivers from Peru.
    Nieto-Juárez JI; Torres-Palma RA; Botero-Coy AM; Hernández F
    Environ Int; 2021 Oct; 155():106674. PubMed ID: 34174591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.